News Focus
News Focus
Followers 24
Posts 4180
Boards Moderated 0
Alias Born 12/18/2019

Re: SkyLimit2022 post# 805370

Tuesday, 12/30/2025 2:31:56 AM

Tuesday, December 30, 2025 2:31:56 AM

Post# of 824213
Ridiculous -- MHRA approval has no bearing on the U.S. decision. If they couldn't afford a U.S. filing, but still had the money to file in UK -- ridiculous. NWBO can't survive on UK business as it will take years and more trials to get full NICE acceptance -- just like Gilead's CAR-T that took 5 years and multiple more trials to get NICE acceptance and beyond the NICE charity that only paid for ~100 patients a year at greatly reduced pricing.

FDA is not going to accept the P3 trial and NWBO certainly doesn't have the money or time to run another P3 trial that took a decade the way they run trials.
This is a company burning shareholder cash through vulture funds, who dilute the hell out of shareholders.

What a con job.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News